NeoGenomics (NEO) 8-K Accounts Receivable (net of allowance for doubtful

Exhibit 99.1

NeoGenomics, Inc.

CONSOLIDATED BALANCE SHEET AS OF

December 31, 2008 and December 31, 2007

(unaudited)

ASSETS	December 31, 2008		December 31, 2007
Cash and cash equivalents	$	468,171	$	210,573
Accounts Receivable (net of allowance for doubtful accounts of $358,642 and $414,548, respectively)		2,913,531		3,236,751
Other Current Assets		973,867		704,918
TOTAL CURRENT ASSETS		4,355,569		4,152,242
PROPERTY AND EQUIPMENT (net of accumulated depreciation of $1,602,594 and $862,030, respectively)		2,875,297		2,108,083
OTHER ASSETS		64,509		260,575
TOTAL	$	7,295,375	$	6,520,900
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES	$	4,390,994	$	3,361,705
LONG TERM LIABILITIES		1,403,271		837,081
TOTAL LIABILITIES		5,794,265		4,198,786
STOCKHOLDERS’ EQUITY		1,501,110		2,322,114
TOTAL	$	7,295,375	$	6,520,900

1

NeoGenomics, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

	For the Twelve- Months Ended  December 31, 2008			For the Twelve- Months Ended December 31, 2007			For the Three- Months Ended  December 31, 2008			For the Three- Months Ended December 31, 2007
REVENUE	$	20,015,319		$	11,504,725		$	5,920,360		$	3,795,316
COST OF REVENUE		9,353,852			5,522,775			2,776,302			1,898,914
GROSS PROFIT		10,661,467			5,981,950			3,144,058			1,896,402
OPERATING EXPENSES:
Selling, general and administrative		11,545,456			9,122,922			3,839,172			3,458,869
Total operating expenses		11,545,456			9,122,922			3,839,172			3,458,869
Income (loss) from operations		(883,989	)		(3,140,972	)		(695,114	)		(1,562,467	)
Other income (loss)
Interest income/(expense), net		(298,597	)		(239,200	)		(99,261	)		(33,395	)
Loss on investments		(200,000	)		-			(200,000	)		-
Other Income (loss)		(498,597	)		(239,200	)		(299,261	)		(33,395	)
NET INCOME (LOSS)	$	(1,382,586	)	$	(3,380,172	)	$	(994,375	)	$	(1,595,862	)
NET INCOME (LOSS) PER SHARE  - Basic and Diluted	$	(0.04	)	$	(0.11	)	$	(0.03	)	$	(0.05	)
WEIGHTED AVERAGE NUMBER    OF SHARES OUTSTANDING –    Basic and Diluted		31,506,824			29,764,289			31,870,605			31,374,096

2

NeoGenomics, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

	For the Twelve-Months Ended December 31, 2008			For the Twelve-Months Ended December 31, 2007
NET CASH USED IN OPERATING ACTIVITIES	$	(138,306	)	$	(2,642,591	)
NET CASH USED IN INVESTING ACTIVITIES		(501,781	)		(716,144	)
NET CASH PROVIDED BY FINANCING ACTIVITIES		897,685			3,443,042
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS		257,598			84,307
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		210,573			126,266
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	468,171		$	210,573
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	$	256,323		$	204,670
Income taxes paid	$	-		$	-
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Equipment leased under capital lease	$	1,207,863		$	703,145

3